An undetectable source of technical error that could lead to false negative results in enzyme linked immunosorbent assay of antibodies to HIV-1.
Since the institution of routine testing for antibodies to Human Immunodeficiency Virus (HIV) using the enzyme-linked immunosorbent assay (ELISA), the specificity and sensitivity of this assay system has received significant scrutiny. During previous use of this methodology, we have quantified rates of false biological positive results using commercial kit assays in a normal donor population. In this study, we have identified a potential source for false negative results. Using multiple lots of two different commercial ELISA kits, the absorbance readings at the test end point could not differentiate between normal non-reactive donor samples and blanks containing no sample. These results occur using normal donor samples, even though the assays could distinguish between blank wells and the manufacturers' "normal controls", provided with the assay. Our findings suggest that a technical pipetting error is presently undetectable, either visually or by statistical methods, and could permit an untested, potentially HIV-1 positive, unit to be released into the transfusable blood supply. A possible solution is suggested.
Wiltbank
T B
TB
Department of Pathology, University of Illinois College of Medicine, Peoria.
McCarroll
D R
DR
Wartick
M G
MG
D004797:Enzyme-Linked Immunosorbent Assay / Q000592:standards*; D005188:False Negative Reactions; D015483:HIV Antibodies / Q000032:analysis*; D006801:Humans; D011933:Reagent Kits, Diagnostic; D012015:Reference Standards
D015483:HIV Antibodies; D011933:Reagent Kits, Diagnostic